EFFECTS OF EXTRACORPOREAL MEMBRANE-OXYGENATION ON MORPHINE PHARMACOKINETICS IN INFANTS

被引:45
|
作者
DAGAN, O
KLEIN, J
BOHN, D
KOREN, G
机构
[1] HOSP SICK CHILDREN,DEPT CRIT CARE,TORONTO M5G 1X8,ON,CANADA
[2] HOSP SICK CHILDREN,DEPT PEDIAT,DIV CLIN PHARMACOL TOXICOL,TORONTO M5G 1X8,ON,CANADA
[3] HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ON,CANADA
[4] UNIV TORONTO,DEPT PEDIAT,TORONTO,ON,CANADA
[5] UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON,CANADA
关键词
EXTRACORPOREAL MEMBRANE OXYGENATION; MORPHINE; INFANTS; PHARMACOKINETICS; PHARMACODYNAMICS; SEDATION; DRUG METABOLISM; OPIATES; CRITICAL ILLNESS; PHARMACOLOGY; INTENSIVE CARE UNIT; PEDIATRIC;
D O I
10.1097/00003246-199407000-00008
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To study the effect of extracorporeal membrane oxygenation (ECMO) on the pharmacokinetics of morphine in infants. Design: A prospective, comparative study of morphine pharmacokinetics during and after ECMO. Setting: The pediatric intensive care unit at a children's hospital. Patients: Seven infants, aged 1 day to 12 months, requiring ECMO. Intervention: Infusion of morphine. Measurement and Main Results: Steady-state concentrations of morphine were used to generate a morphine clearance rate. Plasma clearance rate of morphine increased from 0.574 +/- 0.3 L/kg/hr to 1.058 +/- 0.727 L/kg/hr after discontinuation of ECMO (p <.01). Two infants experienced a clinical picture consistent with opioid withdrawal. Conclusion: Infants requiring morphine after ECMO may require higher dose rates to maintain adequate sedation.
引用
收藏
页码:1099 / 1101
页数:3
相关论文
共 50 条
  • [31] 10 YEARS OF EXTRACORPOREAL MEMBRANE-OXYGENATION - NEURODEVELOPMENTAL OUTCOME
    HOFKOSH, D
    THOMPSON, AE
    NOZZA, RJ
    KEMP, SS
    BOWEN, A
    FELDMAN, HM
    PEDIATRICS, 1991, 87 (04) : 549 - 555
  • [32] VASCULAR ACCESS IN THE NEONATE FOLLOWING EXTRACORPOREAL MEMBRANE-OXYGENATION
    FORD, EG
    KITAGAWA, H
    ATKINSON, JB
    JOURNAL OF PEDIATRIC SURGERY, 1990, 25 (06) : 594 - 595
  • [33] HEMODYNAMIC-CHANGES IN NEWBORNS ON EXTRACORPOREAL MEMBRANE-OXYGENATION
    MOLLER, J
    SUSSMANE, J
    VARDAG, A
    RICHTER, A
    WOLFSDORF, J
    PERFUSION, 1991, 4 (09): : 294 - &
  • [34] OUTCOME FOR INFANTS WITH CONGENITAL DIAPHRAGMATIC-HERNIA REQUIRING EXTRACORPOREAL MEMBRANE-OXYGENATION - THE FIRST YEAR
    DAGOSTINO, JA
    BERNBAUM, JC
    GERDES, M
    SCHWARTZ, IP
    COBURN, CE
    HIRSCHL, RB
    BAUMGART, S
    POLIN, RA
    JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (01) : 10 - 15
  • [35] IMPROVED OXYGENATION WITH REDUCED RECIRCULATION DURING VENOVENOUS EXTRACORPOREAL MEMBRANE-OXYGENATION - EVALUATION OF A TEST CATHETER
    RAISBAHRAMI, K
    RIVERA, O
    MIKESELL, GT
    SEALE, WR
    SELL, JE
    SHORT, BL
    CRITICAL CARE MEDICINE, 1995, 23 (10) : 1722 - 1725
  • [36] Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation
    An, Sook Hee
    Lee, Eun Mi
    Kim, Jae Yeon
    Gwak, Hye Sun
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (E1) : E25 - E29
  • [37] Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
    Zylbersztajn, Brenda
    Parker, Suzanne
    Navea, Daniel
    Izquierdo, Giannina
    Ortiz, Paula
    Pablo Torres, Juan
    Fajardo, Cristian
    Diaz, Rodrigo
    Valverde, Cristian
    Roberts, Jason
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation
    Moffett, Brady S.
    Morris, Jennifer
    Galati, Marianne
    Munoz, Flor
    Arikan, Ayse A.
    PEDIATRIC CRITICAL CARE MEDICINE, 2018, 19 (10) : 973 - 980
  • [40] Pharmacotherapy in Neonatal and Pediatric Extracorporeal Membrane Oxygenation (ECMO)
    Wildschut, E. D.
    Ahsman, M. J.
    Houmes, R. J.
    Pokorna, P.
    de Wildt, S. N.
    Mathot, R. A. A.
    Tibboel, D.
    CURRENT DRUG METABOLISM, 2012, 13 (06) : 767 - 777